MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood.2024024283

Медицинская библиотека · Blood · 2024

ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies.

Elitzur Sarah, Shiloh Ruth, Loeffen Jan L C, Pastorczak Agata, Takagi Masatoshi, Bomken Simon, Baruchel Andre, Lehrnbecher Thomas, Tasian Sarah K, Abla Oussama, Arad-Cohen Nira, Astigarraga Itziar, Ben-Harosh Miriam, Bodmer Nicole, Brozou Triantafyllia, Ceppi Francesco, Chugaeva Liliia, Dalla Pozza Luciano, Ducassou Stephane, Escherich Gabriele, Farah Roula, Gibson Amber, Hasle Henrik, Hoveyan Julieta, Jacoby Elad, Jazbec Janez, Junk Stefanie, Kolenova Alexandra, Lazic Jelena, Lo Nigro Luca, Mahlaoui Nizar, Miller Lane, Papadakis Vassilios, Pecheux Lucie, Pillon Marta, Sarouk Ifat, Stary Jan, Stiakaki Eftichia, Strullu Marion, Tran Thai Hoa, Ussowicz Marek, Verdu-Amoros Jaime, Wakulinska Anna, Zawitkowska Joanna, Stoppa-Lyonnet Dominique, Taylor A Malcolm, Shiloh Yosef, Izraeli Shai, Minard-Colin Veronique, Schmiegelow Kjeld, Nirel Ronit, Attarbaschi Andishe, Borkhardt Arndt

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Ataxia-telangiectasia (A-T) is an autosomal-recessive disorder caused by pathogenic variants (PVs) of the ATM gene, predisposing children to hematological malignancies. We investigated their characteristics and outcomes to generate data-based treatment recommendations. In this multinational, observational study we report 202 patients aged ≤25 years with A-T and hematological malignancies from 25 countries. Ninety-one patients (45%) presented with mature B-cell lymphomas, 82 (41%) with acute lymphoblastic leukemia/lymphoma, 21 (10%) with Hodgkin lymphoma and 8 (4%) with other hematological malignancies. Four-year overall survival and event-free survival (EFS) were 50.8% (95% confidence interval [CI], 43.6-59.1) and 47.9% (95% CI 40.8-56.2), respectively. Cure rates have not significantly improved over the last four decades (P = .76). The major cause of treatment failure was treatment-related mortality (TRM) with a four-year cumulative incidence of 25.9% (95% CI, 19.5-32.4). Germ line ATM PVs were categorized as null or hypomorphic and patients with available genetic data (n = 110) were classified as having absent (n = 81) or residual (n = 29) ATM kinase activity. Four-year EFS was 39.4% (95% CI, 29-53.3) vs 78.7% (95% CI, 63.7-97.2), (P < .001), and TRM rates were 37.6% (95% CI, 26.4-48.7) vs 4.0% (95% CI, 0-11.8), (P = .017), for those with absent and residual ATM kinase activity, respectively. Absence of ATM kinase activity was independently associated with decreased EFS (HR = 0.362, 95% CI, 0.16-0.82; P = .009) and increased TRM (hazard ratio [HR] = 14.11, 95% CI, 1.36-146.31; P = .029). Patients with A-T and leukemia/lymphoma may benefit from deescalated therapy for patients with absent ATM kinase activity and near-standard therapy regimens for those with residual kinase activity.

Для цитирования: Elitzur Sarah, Shiloh Ruth, Loeffen Jan L C, Pastorczak Agata, Takagi Masatoshi, Bomken Simon, Baruchel Andre, Lehrnbecher Thomas, Tasian Sarah K, Abla Oussama, Arad-Cohen Nira, Astigarraga Itziar, Ben-Harosh Miriam, Bodmer Nicole, Brozou Triantafyllia, Ceppi Francesco, Chugaeva Liliia, Dalla Pozza Luciano, Ducassou Stephane, Escherich Gabriele, Farah Roula, Gibson Amber, Hasle Henrik, Hoveyan Julieta, Jacoby Elad, Jazbec Janez, Junk Stefanie, Kolenova Alexandra, Lazic Jelena, Lo Nigro Luca, Mahlaoui Nizar, Miller Lane, Papadakis Vassilios, Pecheux Lucie, Pillon Marta, Sarouk Ifat, Stary Jan, Stiakaki Eftichia, Strullu Marion, Tran Thai Hoa, Ussowicz Marek, Verdu-Amoros Jaime, Wakulinska Anna, Zawitkowska Joanna, Stoppa-Lyonnet Dominique, Taylor A Malcolm, Shiloh Yosef, Izraeli Shai, Minard-Colin Veronique, Schmiegelow Kjeld, Nirel Ronit, Attarbaschi Andishe, Borkhardt Arndt. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies.. Blood. 2024. DOI: 10.1182/blood.2024024283.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.